The Surgical Results in Pure Endoscopic Endonasal Trans-sphenoidal Surgeries in 403 Pituitary Adenomas: An 8-Years of Experience from a Single Neurosurgical Unit

Authors

  • Khalid Mahmood Department of Neurosurgery, Punjab Institute of Neurosciences, Lahore
  • Muhammad Hassan Raza Department of Neurosurgery, Punjab Institute of Neurosciences, Lahore
  • imran Ali Department of Neurosurgery, Punjab Institute of Neurosciences, Lahore
  • Omair Afzal Department of Neurosurgery, Punjab Institute of Neurosciences, Lahore

DOI:

https://doi.org/10.36552/pjns.v24i4.500

Keywords:

Endoscopic Endonasal Approach, Pituitary Adenomas, Complication Rates

Abstract

Objective:  To review and report the results in pure endoscopic endonasal trans-sphenoidal surgery done at our unit for pituitary adenomas (PAs) in last 8 years.

Material and Methods:  We reviewed 403 consecutive patients who underwent pure endoscopic endonasal trans-sphenoidal surgery for newly diagnosed pituitary adenomas between August 2012 and July 2020 at our neurosurgical unit. Endocrinological, demographic features and outcomes, their complications, and duration of stay in hospital were assessed in these patients who were operated in our neurosurgical Unit. The Mean Follow-up on average was 3.5 months.

Results:  403 consecutive cases were reviewed. Majority of cases were in the 4th decade of life at presentation. 227 (56%) were non-functioning pituitary tumors and 176 (44%) were hormone secreting pituitary adenomas. Thirty-one (7.7%) complications were observed in 28 post-operative patients. The most frequently observed complication was diabetes insipidus (temporary in 19 (5%) and permanent in 3 (0.7%) cases), cerebrospinal fluids leaks (5 cases) (5.7%), Syndrome of inappropriate antidiuretic hormone (1 case) (0.2%), internal carotid injury (1 case) (0.2%), Empty Sella syndrome (1) (0.2%) and post-operative cardiac complication (1 case) (0.2%). The Follow-up on average was 3.5 months.

Conclusions:  The pure endoscopic endonasal trans-sphenoidal surgery of pituitary adenomas provides acceptable and reasonable results representing a safe alternative procedure to the traditional Trans-sphenoidal microscopic approach.

References

1. Sun G, Cao Y, Jiang N, et al. Binostril endoscopic transsphenoidal neurosurgery for pituitary adenomas: experience with 42 patients. Oncotarget. 2017; 8 (40): 69020-69024.
doi:10.18632/oncotarget.16976
2. Guiot J, Rougerie J, Fourestier M, Fournier A, Comoy C, Vulmiere J et al. [Intracranial endoscopic explorations]. Presse Med. 1963; 71: 1225-8. French.
3. Xue-Fei S, Yong-Fei W, Shi-Qi L, Jing-Song W, Yao Z, Ying M et al. Microsurgical treatment for giant and irregular pituitary adenomas in a series of 54 consecutive patients. Br J Neurosurg. 2008; 22 (5): 636-48. doi:10.1080/02688690802346083
4. Berker M, Hazer DB, Yücel T, Gürlek A, Cila A, Aldur M, et al. Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature. Pituitary, 2012; 15 (3): 288-300. doi:10.1007/s11102-011-0368-2
5. Santos RP, Zymberg ST, Abucham Filho JZ, Gregório LC, Weckx LLM. Endoscopic transnasal approach to sellar tumors. Rev Bras Otorrinolaringol. 2007; 73 (4): 463-75.
doi:10.1590/S0034-72992007000400005
6. Komotar RJ, Starke RM, Raper DM, Anand VK, Schwartz TH. Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas. Pituitary, 2012; 15 (2): 150-9. doi:10.1007/s11102-011-0359-3
7. Cecenarro LA, Rodrigo Fanton ET, Estario P, Papalini RF, Estario ME. Pituitary tumors: 10 years of experience. Rev FacCien Med Univ Nac Cordoba. 2015; 72: 32-38.
8. Singh H, Essayed WI, Cohen-Gadol A, Zada G and Schwartz TH. Resection of pituitary tumors: endoscopic versus microscopic. J Neurooncol. 2016; 130: 309.

Downloads

Published

2021-01-01

Issue

Section

Original Articles